Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2025-12-24 @ 4:40 PM
NCT ID: NCT06148766
Eligibility Criteria: Inclusion Criteria: * Female. * 40-55 years of age. * Must be in good general health. * Must have concerns with overall skin health and appearance, including: Fine lines and wrinkles The appearance of dark spots * Must be using the same cleanser and toner for at least one month prior to starting the study. * Must be willing to keep using the same cleanser and toner for the duration of the study. * Must not be using oral or topical retinoids. * In the last three months, has not introduced any new medications or supplements that target skin health. * Must be willing to comply with the protocol. Exclusion Criteria: * Anyone with an allergy to bees or bee products. * Females who are pregnant or breastfeeding. * Unwilling to follow the protocol. * Unwilling to maintain use of the same cleaner and toner for the duration of the study. * Currently participating in another study. * Use of oral or topical retinoids. * Individuals with cystic acne or otherwise self-reported very acne-prone skin. * Use of a prescription medication relevant to the skin. * Anyone undergoing cosmetic procedures during the study, including Botox, laser, or chemical peel treatments. * Anyone sensitive or allergic to any ingredients found in the products. * Anyone with severe chronic conditions, including oncological conditions, psychiatric disorders or diabetes.
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 40 Years
Maximum Age: 55 Years
Study: NCT06148766
Study Brief:
Protocol Section: NCT06148766